Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients
about
Is There Still Room for Cancer Vaccines at the Era of Checkpoint InhibitorsCD137 and CD137L signals are main drivers of type 1, cell-mediated immune responsesTherapeutic potential of anti-CD137 (4-1BB) monoclonal antibodies.Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes.CD8(+) T cell response to adenovirus vaccination and subsequent suppression of tumor growth: modeling, simulation and analysisOncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8(+) T-cell responses to anticancer vaccinesNext Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.Inferring the Impact of Regulatory Mechanisms that Underpin CD8+ T Cell Control of B16 Tumor Growth In vivo Using Mechanistic Models and Simulation.Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor.Manipulating the PD-1 pathway to improve immunity.Synergistic effect of programmed cell death protein 1 blockade and secondary lymphoid tissue chemokine in the induction of anti-tumor immunity by a therapeutic cancer vaccine.Human Tumor Antigens and Cancer Immunotherapy.SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors.Adaptive Resistance to Cancer Immunotherapy.Oncolytic virus and PD-1/PD-L1 blockade combination therapy
P2860
Q28072532-59EFA05A-3FF2-48AE-9CF6-C0308B816B6EQ28072933-03A8E76A-8B6F-4231-81CC-598CB648E230Q33426409-A7B87F7E-8E66-422D-94D1-6B1B688661E5Q34548226-FDAC9CCC-D408-46B4-82B3-7F0B81B3A138Q35655089-680F035C-28BD-4856-A621-8C8385C68751Q37196054-852A47BD-1B4F-4DBC-AB1F-BE6CA9C8BBE0Q37320156-6106E9CC-8F0D-4ACB-8C23-D043B19A72F3Q37554202-31AF5F26-C1A3-42AE-9F2F-B5112FA363C7Q37690444-4DE54648-E23E-44D7-908F-8A6A057CF130Q38098681-7C0E014E-0C42-4201-801F-27BA2D00036EQ40517920-BCA52226-09AF-44E0-9058-97DC0D9864BDQ41533232-3C2265D3-4D18-4D50-B021-98015DEDCD76Q41939949-C29C7C6E-E124-41CE-A438-ECBCB0EA824BQ47252744-F259AA46-33C4-42DF-BDEA-551A53A3CA00Q57174025-ABE3F006-C079-44DF-AAB1-8E33A3D096B7
P2860
Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Combined vaccination and immun ...... ome in human melanoma patients
@ast
Combined vaccination and immun ...... ome in human melanoma patients
@en
type
label
Combined vaccination and immun ...... ome in human melanoma patients
@ast
Combined vaccination and immun ...... ome in human melanoma patients
@en
prefLabel
Combined vaccination and immun ...... ome in human melanoma patients
@ast
Combined vaccination and immun ...... ome in human melanoma patients
@en
P2093
P2860
P356
P1433
P1476
Combined vaccination and immun ...... ome in human melanoma patients
@en
P2093
A J Robert McGray
Caitlin Gregory
Dannie Bernard
Jennifer D Bassett
John A Hassell
Mayank Jha
Robin Hallett
Ryan Kelly
Yonghong Wan
P2860
P304
P356
10.4161/ONCI.19534
P577
2012-07-01T00:00:00Z